Impact Of Merck Litigation On Ionis Pharmaceuticals

Impact Of Merck Litigation On Ionis Pharmaceuticals


Ionis has the cash necessary to advance its pipeline, so it is not necessarily reliant upon a verdict with Gilead in order to meet targets. The much watched litigation between Gilead Sciences and Merck appears as though it is rapidly heading towards a jury verdict.



from Biotech News